We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Domain Therapeutics Opens a North American Subsidiary at Montreal's NEOMED Institute

Canada-based Domain Therapeutics NA Inc. will focus exclusively on leveraging the BioSens-All™ technology.
News

Novasep Attracts Top Talent to Complete its Executive Team

Thierry Van Nieuwenhove, a seasoned CMO top executive, joins Novasep as president of the Synthesis Business Unit.
News

Debiopharm Announces Completion of Recruitment for Phase III Clinical Study in CPP

Completion of recruitment and results are expected in Q4 2014.
News

Bruker Corporation Appoints Dr. Gilles Martin to its Board of Directors

Dr. Martin is Chairman and Chief Executive Officer of the Eurofins Scientific Group.
News

BioLineRx Announces Regulatory Submission for Novel Stem Cell Mobilization Treatment

Phase 1 trial of BL-8040 expected to begin in Q2 2014.
News

TAP Biosystems Presents New Data on 3D Cell Culture Research

Discussing the application of RAFT 3D models in oncology, toxicology and neuroscience cell-based screening programmes.
News

Reaction Biology and Cisbio Sign Distribution Agreement

Agreement will see Cisbio distribute Reaction Biology's epigenetic proteins.
News

Innova Biosciences and TGR BioSciences Announce Co-Marketing Agreement

Companies enter into an agreement to promote and co-market each other’s highly complementary technologies.
News

Adocia Strengthens its Diabetic Foot Ulcer Patent Portfolio

The patent on the BioChaperone® polymer used in the PDGF composition recently granted in the United States.
News

Gene Therapy Trial Shows Promise for Type of Blindness

Patients showed improvements in their vision in dim light and two of the six were able to read more lines on the eye chart.
Advertisement